Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Apr 17;20(6):351. doi: 10.1038/s41577-020-0318-1

A map of SARS-CoV-2 and host cell interactions

Louise Malle 1,
PMCID: PMC7186929  PMID: 32303698

Currently, little is known about the molecular interactions between SARS-CoV-2 and its host. In this preprint, Gordon et al. cloned, tagged and expressed 26 of 29 SARS-CoV-2 proteins individually in HEK293T cells and used mass spectrometry to measure protein–protein interactions. They identified 332 interactions between viral and host proteins, and several viral proteins (including N, nsp9, nsp13, nsp15, ORF3a and ORF6) were found to directly target cellular proteins involved in innate immune signalling. Furthermore, they noted 69 existing drugs known to target host proteins or associated pathways that interact with SARS-CoV-2. Overall, this ‘SARS-CoV-2 interaction map’ paves the way to better understand how the virus hijacks its host during infection and provides promising therapeutic candidates.

Competing interests

The author declares no competing interests

References

Original article

  1. Gordon DE, et al. A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. 2020 doi: 10.1101/2020.03.22.002386. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES